RecruitingNCT05752604

Impact of Conventional Treatments and Clinical Variables on Thyroid Cancer

Retrospective and Prospective Evaluation of the Impact of Innovative and Conventional Treatments and of Clinical Variables on the Outcome of Thyroid Cancer

Sponsor

Istituto Auxologico Italiano

Enrollment

3,000 participants

Start Date

Jul 12, 2022

Study Type

OBSERVATIONAL

Conditions

Thyroid Cancer

Summary

DTC has a generally favorable prognosis. The possibility to discriminate between patients with aggressive tumors and those with a more indolent behavior may reduce the need for unnecessary treatments. Aim of this observational study is to evaluate how anamnestic, clinical, and histopathological variables may influence the outcome of the enrolled patients, both regarding morbidity and mortality and in terms of therapeutic choices. The study aims to evaluate the prognostic impact of the therapeutic interventions in terms of efficacy and regarding the appearance of adverse events.

Eligibility

Plain Language Summary

Simplified for easier understanding

This study is collecting information from thyroid cancer patients about their treatment history, clinical variables, and outcomes to better understand what factors influence prognosis and how well conventional treatments work for different types of thyroid cancer. **You may be eligible if...** - You have been diagnosed with thyroid cancer **You may NOT be eligible if...** - You are unable or unwilling to sign an informed consent form Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.